Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Neurogastroenterology and Motility

ISSN 1365-2982

3 papers in the library · 95 citations · publishing 2006-2020

Papers

The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.

Neurogastroenterology and Motility January 1, 2006 R Capasso, F Borrelli, F Capasso et al. 56 citations

An extract from the hallucinogenic herb Salvia divinorum reduces nerve-induced muscle contractions in guinea-pig ileum by acting on kappa-opioid receptors. The extract lowered electrically evoked contractions without affecting responses to added acetylcholine, indicating a prejunctional site of action. This effect was blocked by the opioid antagonist naloxone and the kappa-opioid antagonist nor-binaltorphimine, but not by antagonists for delta- or mu-opioid receptors or other receptors. Salvinorin A, the main active ingredient, similarly inhibited contractions. The findings suggest that kappa-opioid receptor activation underlies the herb's traditional antidiarrhoeal use.

The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.

Neurogastroenterology and Motility February 1, 2008 R Capasso, F Borrelli, J Zjawiony et al. 39 citations

An extract from the hallucinogenic plant Salvia divinorum and its active ingredient salvinorin A reduce gut motility in mice, but only during intestinal inflammation. In healthy mice, salvinorin A slowed motility only at high doses, and this effect did not involve kappa-opioid receptors (KOR). Inflammation made salvinorin A more potent at lower doses, and this effect was blocked by KOR antagonists, indicating a switch to KOR-mediated action. A standard KOR agonist did not share this enhanced potency, suggesting salvinorin A may act through additional targets in the inflamed gut.

Mindfulness‐based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness

Neurogastroenterology and Motility April 7, 2020 B. Naliboff, Suzanne R. Smith, J. G. Serpa et al.

Mindfulness-based stress reduction (MBSR) is associated with reduced gastrointestinal symptoms and improved quality of life in people with irritable bowel syndrome. In this single-arm intervention study, changes in specific aspects of mindfulness were linked to clinical outcomes, suggesting that cultivating particular mindfulness skills may drive the benefits of MBSR for IBS.